Clinic

One single infusion with CAR-T cells replaces immune-suppressive medicines In March 2021, doctors from FAU treated a young woman with a severe autoimmune disease with chimeric antigen receptor (CAR) T-cells, the first time a treatment of this kind has been attempted anywhere in the world. Today, ne...

Invitation to a Patient Event on September 19, 2023, on Treatment Options for Arthritis – Live Demonstration of the New Surgical Robot Arthritis is one of the most common diseases worldwide. To this day, joint wear and tear cannot be cured; only the symptoms and associated limitations can be treate...

New Hybrid Lecture Series Starting from September 13, 2023: Hector Center Focuses on Topics Related to Nutrition Trends, Exercise, and More Is sugar always unhealthy? How can you positively influence your gut flora? What impact does muscle mass have on health? And how can you incorporate Mediterran...

Team from the University Hospital Erlangen and FAU Identifies Differentiation Step Essential for Antiviral Immune Responses Dendritic cells are crucial for orchestrating immune responses: They patrol all tissues of the body, capturing invaders like viruses and bacteria, and subsequently trigger an ...

Research Team Paves the Way for More Efficient AI Artificial Intelligence (AI), especially the training of AI systems like ChatGPT, consumes vast amounts of energy. If AI could operate more like human brains, it would be significantly more efficient. Dr. Achim Schilling and Dr. Patrick Krauss from ...

The Jakob Herz Prize was awarded for the seventh time on Friday October 7, 2022. The prize is awarded together with the Research Foundation at Universitätsklinikum Erlangen every two years for outstanding scientific achievements from theoretical and clinical medicine. This year’s award winner Prof. Dr. Douglas F. Easton from Cambridge (England), received the Jakob Herz Prize in recognition of his breakthroughs in breast cancer research.

Dr. Adran Regensburger, a doctor in the Department of Pediatrics and Adolescent Medicine, has received the ‘Young Investigator Award’ for his work in molecular imaging in children with muscular dystrophy. The jury particularly praised the innovatory value and method selected by Dr. Regensburger.

In 2012, UK Erlangen was the first hospital in Middle Franconia to use a robot-assisted surgical system. The hospital has now invested over 2.4 million euros in a new da Vinci Xi to enable it to increase the precision of surgical procedures in the future with the latest generation of the robot-assisted surgical system.

An important step on the path towards creating an artificial ovary for patients suffering from cancer: Scientists at FAU are researching innovative techniques for restoring fertility in cancer patients.